日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細


公開

学術論文

An autoreactive γδ TCR Derived from a Polymyositis Lesion

MPS-Authors
/persons/resource/persons191380

Weltzien,  Hans-Ulrich
Emeritus Group: Cellular Immunology, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

External Resource
There are no locators available
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
フルテキスト (公開)
公開されているフルテキストはありません
付随資料 (公開)
There is no public supplementary material available
引用

Wiendl, H., Malotka, J., Holzwarth, B., Weltzien, H.-U., Wekerle, H., Hohlfeld, R., & Dornmair, K. (2002). An autoreactive γδ TCR Derived from a Polymyositis Lesion. Journal of Immunology, 169(1), 515-521.


引用: https://hdl.handle.net/11858/00-001M-0000-002B-962A-8
要旨
To investigate the role of γδ T cells in human autoimmune disease we expressed and characterized a γδ TCR from an autoimmune tissue lesion. The TCR was first identified in a rare form of polymyositis characterized by a monoclonal infiltrate of gammadelta T cells which invaded and destroyed skeletal muscle fibers. The Vγ1.3-Jγ1-Cγ1/Vδ2-Jδ3 TCR cDNA of the original muscle invasive γδ T cell clone was reconstructed from unrelated cDNA and transfected into the mouse hybridoma BW58αβ. Appropriate anti-human γδ TCR Abs stimulated the TCR transfectants to produce IL-2, thus demonstrating that the human γδ TCR functionally interacted with murine signaling components. The transfected Vγ1.3/Vδ2 TCR recognized a cytosolic protein expressed in cultured human myoblasts and TE671 rhabdomyosarcoma cells. The Ag was recognized in the absence of presenting cells. Using a panel of control γδ TCR transfectants with defined exchanges in different positions of both TCR chains, we showed that the γδ TCR recognized its Ag in a TCR complementarity-determining region 3-dependent way. To our knowledge, this is the first example of a molecularly defined γδ TCR directly derived from an autoimmune tissue lesion. The strategy used in this study may be applicable to other autoimmune diseases.